Literature DB >> 20231344

Rationalizing the clinical use of frozen plasma.

Peter H Pinkerton1, Jeannie L Callum.   

Abstract

Mesh：

Year:  2010        PMID： 20231344      PMCID： PMC2900323          DOI： 10.1503/cmaj.081933

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines.

Authors:  Cynthia Luk; Kathleen M Eckert; Robert M Barr; Ian H Chin-Yee
Journal:  CMAJ       Date:  2002-06-11       Impact factor: 8.262

2.  Guidelines for the use of fresh frozen plasma.

Authors:  D De Backer; B Vandekerckhove; S Stanworth; L Williamson; C Hermans; P Van der Linden; R Hübner; P Baele; K Jochmans; A Ferrant; M Lambermont; L Muylle; M Toungouz
Journal:  Acta Clin Belg       Date:  2008 Nov-Dec       Impact factor: 1.264

3.  Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.

Authors:  Omar I Abdel-Wahab; Brian Healy; Walter H Dzik
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

Review 4.  Transfusion-related acute lung injury.

Authors:  Christopher C Silliman; Daniel R Ambruso; Lynn K Boshkov
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

5.  Population-based audit of fresh-frozen plasma transfusion practices.

Authors:  Riikka Palo; Leena Capraro; Seppo Hovilehto; Merja Koivuranta; Tom Krusius; Elina Loponen; Ritva Mäntykoski; Jussi Pentti; Otto Pitkänen; Maria Raitakari; Jussi Rimpiläinen; Markku Salmenperä; Hanna Salo; Tiina Mäki
Journal:  Transfusion       Date:  2006-11       Impact factor: 3.157

6.  Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.

Authors:  D F O'Shaughnessy; C Atterbury; P Bolton Maggs; M Murphy; D Thomas; S Yates; L M Williamson
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

Review 7.  The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.

Authors:  Simon J Stanworth
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

8.  Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.

Authors:  Pratima Chowdary; Pratima Chowdhury; Anton G Saayman; Ulrike Paulus; George P Findlay; Peter W Collins
Journal:  Br J Haematol       Date:  2004-04       Impact factor: 6.998

9.  Fresh frozen plasma transfusion in critically ill patients.

Authors:  François Lauzier; Deborah Cook; Lauren Griffith; Julia Upton; Mark Crowther
Journal:  Crit Care Med       Date:  2007-07       Impact factor: 7.598

10.  Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis.

Authors:  A M Audet; C Andrzejewski; M A Popovsky
Journal:  Orthopedics       Date:  1998-08       Impact factor: 1.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.